In der Wochensicht ist vorne: Biogen Idec 5,73% vor Amgen 2,95%, Sartorius 2,81%, Epigenomics 2,5%, Stratec Biomedical 2,5%, Gilead Sciences 1,82%, Baxter International 1,68%, Merck Co. 0,29%, Bayer 0,27%, Pfizer -0,09%, Qiagen -0,69%, Evotec -0,8%, GlaxoSmithKline -1,17%, BASF -1,56%, Roche Holding -1,67%, MorphoSys -2,23%, Novartis -2,49%, Mologen -2,92%, Sanofi -3,12%, BB Biotech -3,66%, Medigene -4,08%, Paion -5,19% und Valneva -6,32%. In der Monatssicht ist vorne: Gilead Sciences 8,36% vor Biogen Idec 4,02% , Epigenomics 1,47% , Baxter International 1,36% , Mologen 0,44% , Sartorius 0,22% , Stratec Biomedical -0,03% , Pfizer -0,09% , Amgen -1,74% , Qiagen -2,65% , Merck Co. -4,1% , MorphoSys -5% , Roche Holding -5,07% , Sanofi -5,4% , Novartis -5,69% , GlaxoSmithKline -5,93% , Bayer -7,13% , BB Biotech -7,91% , BASF -8,44% , Valneva -8,69% , Evotec -12,04% , Medigene -12,33%...
↧